Researchers from Syracuse University (NY, USA) have developed a novel class of nanobiosensor that could detect, characterize and analyze protein–protein interactions in blood serum to assist in cancer detection.
Researchers have developed a new nanoplasmonic biosensor device that precisely detects the presence of anticoagulants in blood samples.
Researchers have developed a novel noninvasive monitor using a technique named Raman spectroscopy for measuring blood glucose levels.
A team from the UC Davis MIND Institute and NeuroPointDX (CA, USA) have developed a metabolic blood test that could identify approximately 17% of children with autism spectrum disorder (ASD).
Time-of-flight secondary ion mass spectrometry utilized in novel technique to map tumor cell signaling
A team from the University of Washington (WA, USA) has demonstrated the use of time-of-flight secondary ion mass spectrometry for mapping tumor cell signals in pancreatic cancer mouse models.
Find out more about a novel biosensor for the real time oxygen monitoring for organ-on-a-chip systems, and a liquid biopsy for predicting lymphoma therapy success.
Definitive profiling of plasma bile acids as potential biomarkers for human liver diseases using UPLC–HRMS
Find out more about this investigation into a thorough and rapid profiling of bile acids in human plasma in this article from Bioanalysis.
Find out more about the co-development agreement between Xbrane and STADA for a ranibizumab biosimilar, and about a novel biomarker test for establishing lung cancer risk in smokers in this week’s bioanalytical news round-up.
Find out more about the consequences of utilizing biomarker assays in drug development without being validated correctly, in this Perspective from Bioanalysis.
Read more about the top stories in new technology developments in this week’s news round-up.